Over the past few months, we have identified key concerns of our clients and of the industry with respect to implementing these changes. I am confident that this panel will foster discussion that proves valuable to those grappling with these changes."
Whitehouse, NJ (PRWEB) June 06, 2016
Whitehouse Laboratories is excited to announce that it has accepted an invitation to participate on a USP 661 Panel discussion at MD&M East. The panel discussion, titled “Putting the Changing USP Packaging Chapters to Work” will follow the formal session. Both the session and the panel discussion will address key issues regarding USP Container testing and the impact of recent revisions and pending changes to USP chapters on the industry. Key participants include moderator Dwain L. Sparks, a Strategic Advisor and Expert Consultant, YourEncore (Eli Lilly and Company retiree), Brandon Zurawlow, CCIT Associate Director, Whitehouse Laboratories and Dan Malinowski - Senior Director Package Technology & Innovation Pfizer. The session is being held June 16 at the EastPack Pharmaceutical and Medical Packaging conference (co-located with MD&M East).
"Whitehouse Laboratories is proud to announce that we are fully functional with respect to the new USP 661.1 and 661.2. We pride ourselves at providing our clients with all necessary capabilities” commented Mark Stier, General Manager of Whitehouse Laboratories. "We are happy to be returning to MD&M East to discuss the Laboratory's Medical Device Testing capabilities with our clients."
“Whitehouse Labs is on the frontlines with our clients, working to ensure that their container and package systems meet new regulatory requirements. Review, understanding, and experience with the specific current and proposed test procedures are imperative to successful implementation,” says Zurawlow. "Over the past few months, we have identified key concerns of our clients and of the industry with respect to implementing these changes. I am confident that this panel will foster discussion that proves valuable to those grappling with these changes."
“We are very excited about this session on the changing USP packaging-related chapters. USP’s Desmond Hunt will provide key updates on the revised chapters and upcoming work, and then our panelists will tackle some challenging questions during the panel discussion, such as what testing must be conducted on plastic packaging systems used for a new drugs,” explains Daphne Allen, editor of Pharmaceutical & Medical Packaging News, who is also serving as conference producer for the event. “Brandon took part in last year’s informative panel discussion on USP packaging chapters and we are pleased to have him join us again in our June 16 session.”
Please visit Whitehouse Laboratories at booth number 566 to discuss Medical Device Testing and other testing services.
For more information and to register for MD&M East, please visit this link.
About Whitehouse Laboratories
The leader in testing, Whitehouse Labs, a division of Albany Molecular Research Inc., offers comprehensive analytical services providing support for manufacturing from development to market. From analytical chemistry and material qualification to packaging optimization, Whitehouse Laboratories is the testing partner for the world's leading Pharmaceutical, Biotechnology, Medical Device, Life Sciences and Consumer Products organizations.